Steven Kong
Physician Assistant · Brooklyn, NYNPI 1407142052
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $43,745 of the $65,879 with a category attached, or 66.4%. 28 manufacturers reported payments, led by Gilead at 48.2% of the total. Reporting peaked in 2021 at $21,564 and has fallen 50.9% since, to $10,580 in 2025. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 809 payments — averaging $81.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$32K
- Biohaven Pharmaceuticals, Inc.$13K
- Biohaven Pharmaceutical Holding Company Ltd.$6K
- AbbVie$3K
- AstraZeneca$3K
- Esperion Therapeutics, Inc.$2K
- plus $8K from 22 others
What the payments were for
- Speaking & faculty fees$43,74566%
- Travel & lodging$1,3542%
- Food & beverage$20,67931%
- Gifts$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 122 | $31,763 |
| Biohaven Pharmaceuticals, Inc. | 54 | $12,566 |
| Biohaven Pharmaceutical Holding Company Ltd. | 31 | $5,676 |
| AbbVie | 57 | $2,696 |
| AstraZeneca | 85 | $2,620 |
| Esperion Therapeutics, Inc. | 85 | $2,398 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 154 | $1,842 |
| Amgen(2 entities) | 57 | $1,330 |
| Pfizer | 36 | $826 |
| Johnson & Johnson | 16 | $604 |
| Amarin Pharma, Inc. | 25 | $567 |
| Galderma Laboratories, L.p. | 9 | $408 |
| Phathom Pharmaceuticals, Inc. | 3 | $373 |
| Madrigal Pharmaceuticals | 6 | $277 |
| Lilly USA, LLC | 9 | $276 |
| Novo Nordisk | 17 | $276 |
| GSK | 5 | $262 |
| IBSA Pharma Inc. | 3 | $262 |
| Vifor Pharma, Inc. | 8 | $243 |
| Boehringer Ingelheim | 9 | $197 |
| Intra-sana Laboratories | 2 | $120 |
| Ardelyx, Inc. | 3 | $79 |
| Ironwood Pharmaceuticals, Inc | 4 | $68 |
| Redhill Biopharma Inc. | 3 | $53 |
| Merck | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Bayer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$65,879 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VascepaIcosapent Ethyl | 2,539 | $921,323 |
| NexletolBempedoic Acid | 1,306 | $604,367 |
| FarxigaDapagliflozin Propanediol | 477 | $275,440 |
| VemlidyTenofovir Alafenamide | 195 | $272,851 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 388 | $245,793 |
| XareltoRivaroxaban | 387 | $226,849 |
| JanuviaSitagliptin Phosphate | 381 | $223,206 |
| Evenity (2 Syringes)Romosozumab-Aqqg | 88 | $207,593 |
| JardianceEmpagliflozin | 327 | $201,225 |
| ProliaDenosumab | 115 | $194,146 |
| RybelsusSemaglutide | 154 | $152,457 |
| CreonLipase/Protease/Amylase | 152 | $139,661 |
| TrulancePlecanatide | 232 | $128,938 |
| Diclofenac Epolamine | 172 | $112,973 |
| Dexlansoprazole DrDexlansoprazole | 587 | $101,324 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Esperion Therapeutics, Inc.Nexletol | $2,398 | $604,3671,306 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Nexium | $2,620 | $549,749971 claims |
| AmgenEvenity (2 Syringes), Prolia | $1,330 | $401,739203 claims |
| MerckJanuvia, Janumet | $32 | $288,184496 claims |
| AbbVieCreon, Restasis, Linzess | $2,696 | $279,694378 claims |
| GileadVemlidy | $31,763 | $272,851195 claims |
| Boehringer IngelheimJardiance, Tradjenta | $197 | $237,713400 claims |
| Johnson & JohnsonXarelto | $604 | $226,849387 claims |
| Novo NordiskRybelsus, Ozempic | $276 | $208,228213 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance, Xifaxan | $1,842 | $155,233244 claims |
| PfizerEliquis, Nurtec Odt | $826 | $100,820129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Brooklyn
- Kaitlyn NelsonBrooklyn$289K
- Melissa VelezBrooklyn$68K
- Hong ChenBrooklyn$57K
- Lindsey AxtBrooklyn$52K
- Gregory CelestinBrooklyn$41K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.